Mitochondrial and cellular components affected by Reactive Oxygen Species (ROS) (ROS-affected components)

Mitochondrial and cellular components affected by Reactive Oxygen Species (ROS) encompass a diverse group of biological molecules, including mitochondrial DNA (mtDNA), membrane phospholipids, and various proteins that undergo oxidative modification. ROS are natural byproducts of aerobic metabolism, primarily generated within the mitochondrial electron transport chain; however, an imbalance between ROS production and antioxidant defenses leads to oxidative stress (NIH, 2023). This stress results in lipid peroxidation, protein carbonylation, and DNA strand breaks, which collectively impair cellular function and trigger programmed cell death (PubMed, PMID: 28235565). These damaged components are central to the pathogenesis of numerous conditions, such as Alzheimer's disease, Parkinson's disease, and atherosclerosis. Pharmacological intervention generally involves the use of antioxidants or mitochondria-targeted scavengers designed to neutralize excess ROS and preserve the structural and functional integrity of these cellular elements (StatPearls, 2023). Because this term describes a broad range of damaged substrates rather than a single protein or receptor, it is often categorized as a pathological state or a set of biomarkers rather than a discrete therapeutic target. Effective drug development in this area requires high specificity to avoid interfering with essential redox-sensitive signaling pathways required for normal cell health.

Other names

Oxidative stress targetsROS-damaged moleculesMitochondrial ROS targetsRedox-sensitive cellular components

Antioxidant scavenging, inhibition of ROS-generating enzymes, and enhancement of endogenous antioxidant systems.